The Student understands and agrees that NCC shall not be held liable for any acts, errors, advice or omissions provided by the Student based on knowledge or advice acquired by NCC
Robert Steinbrook, director of the Public Citizen Health Research Group, terms GLP-1 agonists for weight loss a real-time experiment with unknown long-term risks
This tailored dosing approach helps you achieve the best outcomes while minimizing discomfort
This is not harmful accumulation but intentional, evidence-based dosing that optimises blood glucose control and appetite regulation
Scientific References Frequently Asked Questions Can I start GLP-1 therapy on any day of the week
As body fat decreases, changes in waist size, body shape, and overall appearance can often be seen within the first several weeks